查看完整行情页>>

|

货币单位:美元(USD)

Ayala Pharmaceuticals, Inc.

Ayala Pharmaceuticals, Inc. (adxs)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
证券代码:adxs 公司名称:Ayala Pharmaceuticals, Inc. 公司中文简称:
公司简介:

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded in November 2017 and is headquartered in Monmouth Junction, NJ.

公司网站:
http://www.ayalapharma.com
公司地址:
9 Deer Park Drive Suite K-1 Monmouth Junction